DOBEXIL H UNG

40MG/20MG RCT UNG 1X20G II

SÚKL code 0209939
Name of the product DOBEXIL H UNG
_MA_MEDICATION_DETAIL_INFO_MED_NAME i DOBEXIL H UNG
Supplement 40MG/20MG RCT UNG 1X20G II
Strenght 40MG/20MG
Pharmaceutical form Rectal ointment
Package 1X20G II
Route Rectal use
Language of the pack Czech
Wrap type Tube
Legal status OTC medicinal products
Active substance LIDOCAINE HYDROCHLORIDE MONOHYDRATE (LIDOCAINI HYDROCHLORIDUM MONOHYDRICUM)
CALCIUM DOBESILATE MONOHYDRATE (CALCII DOBESILAS MONOHYDRICUS)
ATC group C05AD01
ATC group name LIDOKAIN

Marketing authorisation information

Registration Number 23/ 026/03-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 03. 2021
MA Holder PharmaSwiss Česká republika s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder Bausch Health Ireland Limited, Dublin
Actual MA holder country IRSKO

Back to list